In this regard, malignant cells can secrete immunosuppressive factors such as Tumor growth factor (TGF)-beta1 derived soluble factors that down-regulate CD26/DPP4 expression in T cells leading to reduced serum CD26/DPP4 activity in cancer patients [32]. The gene discussed is DPP4; the disease is cancer.